Previously unknown group of PFAS compounds detected near Solvay manufacturing site in New Jersey

Feb 17, 2022 | Blogs, Environmental / Industrial | 0 comments

In a recent PFAS fireside chat, Dr. John Washington from the US EPA discussed the findings of a recent study published in Science that detected a novel group of per- and polyfluoroalkyl substances (PFAS)—called chloroperfluoropolyether carboxylates (ClPFPECAs)—in soil samples from New Jersey. The study, conducted by Dr. Washington and his colleagues, detected 10 unique ClPFPECAs in these samples, with the highest concentrations measured near the Solvay manufacturing plant in West Deptford Townhouse, New Jersey, and decreased amounts detected as the distance from the plant increased.

What did the PFAS study find?

The detected novel ClPFPECAs were found to be structurally similar to many of the well-known “legacy” PFAS compounds, such as perfluorooctanoic acid (PFOA), but with notable exceptions. First, in ClPFPECAs, one of the fluorine atoms is replaced by a chlorine near the end of the molecule, which is what makes them “chloroperfluoro-” compounds. Second, ClPFPECAs contain two ether groups in the carbon backbone. However, ClPFPECAs are similar to PFOA in that they contain carboxylic acid functional groups.

So, why were these ClPFPECAs found near the Solvay plant? As noted in the paper, these novel PFAS chemicals are used as processing aids in the manufacturing of fluoropolymers. Previously, Solvay made its fluoropolymers using Surflon, which contains C9, C11 and C13 perfluorinated carboxylic acids (PFCAs). In 2016, however, several manufacturers, including Solvay, agreed to phase out these long-chain PFCAs. It is uncertain, but the ClPFPECAs detected in the study may be used as replacement compounds for Surflon.

For this study, the research team used a combination of targeted and non-targeted analytical techniques. As noted by Dr. Washington, the non-targeted analysis methods were essential to finding these novel PFAS compounds. For example, the distinctive isotope signature of chlorine was used to confirm its presence in the molecules. In addition, techniques such as Kendrick mass defect analysis and the identification of common, diagnostic fragments were used to find other ClPFPECAs in the soil samples.

What do the findings improve our understanding of PFAS risks?

So, what happens to these novel PFAS in the environment? While that’s still unclear, Dr. Washington’s group is involved in investigating transformation at the chlorine site of the molecule, which may indicate that the ClPFPECAs can form other novel PFAS. Stay tuned for the results of this research.

Although the ultimate risk of ClPFPECAs to human and wildlife health remains unknown, this study eloquently demonstrates how mass spectrometry—specifically high resolution accurate mass spectrometry instruments—can be used to improve our understanding of the PFAS “dark matter” that exists in our environment.

*This content does not constitute legal advice. You should consult counsel to assure your procedures comply with applicable law and that it meets your needs.

RUO-MKT-18-14241-A

Sterile but toxic: Cereulide detection in food matrices

In a recent webinar, Ming Gao, Ph.D., Senior Research Chemist at Mérieux NutriSciences, explored the growing challenge of cereulide contamination in food products and the analytical strategies needed to detect this heat-stable toxin at trace levels. The session examined how LC-MS/MS can help laboratories overcome the limitations of traditional microbiological screening and meet emerging regulatory requirements.

How SCIEX Now empowers mass spec users to work with more control, clarity and confidence

In this interview, Andy Wilcox, Senior Market Development Manager, Aftermarket and Software, speaks with Susanna Baqué, Senior Director of Global Customer Experience, about how SCIEX Now gives customers one connected digital workspace to manage instruments, reduce time spent searching for information, resolve issues faster and keep their laboratory running more efficiently and with greater confidence.

Bioanalysis across modalities: Advancing confident decisions with modern LC‑MS strategies

As therapeutic pipelines continue to diversify, bioanalysis is being asked to do more than ever before. From small molecules to complex biologics, today’s scientists must generate high‑quality, reliable data across a growing range of molecule types and workflows, often under increasing time pressure.

Posted by

Craig has worked in the mass spectrometry industry for over 20 years and has been with SCIEX since 2016. As a senior product application specialist, he works with customers to understand their targeted screening workflows and provide solutions using high-resolution accurate mass spectrometry technologies.

Tags


0 Comments

Trackbacks/Pingbacks

  1. Ultra-Sensitive PFAS Analysis: Equipping Labs for a Greener Tomorrow - […] through unique signatures. For instance, he notes a case where the EPA used this method to pinpoint a New…

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network